Scott Longley provides an insight into the unusual new launches in the EIS space, which are open to investors this year.
Give investors the chance to invest in a disruptive tech start-up company that is generating consumer take-up in the sharing economy, and they would likely jump at the chance. Say that the opportunity...
BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.
Classes A and D remain unavailable
Has been sponsor since 2010
Hires RBC's Martin Heale
Bringing over two funds